edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Cantargia has announced that its CAN10 IL1RAP immunology programme has been acquired by Otsuka Pharmaceutical. Deal terms include an upfront payment of US$33m, plus up to US$580m in development, regulatory and commercial milestone payments. The company is also eligible for up to double digits tiered earn-out payments from global product sales. The deal is expected to close within Q325, after which, Otsuka will become responsible for the development and commercialisation of CAN10.
Industrials | Comment
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.